09 January 2021>: Clinical Research
Plasma Heat Shock Protein 90 Alpha: A Valuable Predictor of Early Chemotherapy Effectiveness in Advanced Non-Small-Cell Lung Cancer
Bo Zhong 1ACE , Juxin Shen 1AEG* , Chunyi Zhang 1BDE , Guozhong Zhou 2BE , Yuefang Yu 1DE , E Qin 1BE , Jixian Tang 1DE , Dongping Wu 3DE , Xiaochao Liang 1BEDOI: 10.12659/MSM.924778
Med Sci Monit 2021; 27:e924778
Table 2 Plasma HSP90α levels at different times before and after chemotherapy.
Variable | Before chemotherapy | One cycle of chemotherapy | Two cycles of chemotherapy | Four cycles of chemotherapy | P value |
---|---|---|---|---|---|
HSP90 | 0.42 (0.29, 0.93) | 0.41 (0.28, 0.76) | 0.23 (0.14, 0.35) | 0.17 (0.12, 0.24) |